INDIANAPOLIS and SAN DIEGO, June 7,
2017 /PRNewswire/ -- Time is money in the highly regulated
world of agricultural biotechnology, and the ability to quickly
quantitate endogenous allergens is significant for developing new
products. Progress in this area is being enabled by an
agreement announced today between Dow AgroSciences, a wholly owned
subsidiary of The Dow Chemical Company (NYSE: DOW), and EAG
Laboratories (EAG). The non-exclusive license enables EAG to
utilize Dow AgroSciences' patented intellectual property that
includes Plextein™, a high throughput method for detecting and
quantitating multiple proteins in plants. Historically, testing for
food allergens in soybeans required a dozen different tests, while
using Plextein allows researchers to determine the required
regulatory allergen results in one analysis.
Dow AgroSciences invented Plextein to rapidly identify and
quantify multiple proteins in plant samples. The technology is a
high-throughput method utilizing liquid chromatography coupled with
tandem mass spectrometry (LC-MS/MS) to simultaneously measure
plant-derived proteins of interest to companies and government
regulatory agencies.
"The rapid quantitation of allergens in soybeans helps soybean
product developers quickly and efficiently meet the increasing
regulatory demands around the globe, which ultimately can help
speed products getting into the hands of farmers," says
Tom Meade, PhD, Global Seeds and
Traits Discovery Leader, Dow AgroSciences. "Plextein is highly
effective in getting to the answers that are needed in terms of
potential changes in allergen expression level."
"EAG offers seed and trait developers the unique combination of
biotechnology and protein characterization expertise, more than 50
years' experience analyzing plant matrices, and significant
LC/MS/MS horsepower. Adding the Plextein™ platform to our offering
will enable us to better leverage this know-how and bring our
customers the latest advancements in plant protein analyses," said
Chris Lively, Ph.D., Senior Director
of Biotechnology Services at EAG Laboratories.
About Dow AgroSciences
Dow AgroSciences discovers,
develops, and brings to market crop protection and plant
biotechnology solutions for the growing world. Based in
Indianapolis, Indiana, USA, Dow
AgroSciences is a wholly owned subsidiary of The Dow Chemical
Company and had annual global sales of $6.2
billion in 2016. Learn more at www.dowagro.com. Follow Dow
AgroSciences on Facebook, Twitter, LinkedIn, and Google+, or
subscribe to our News Release RSS Feed.
About EAG
EAG, Inc., is a global scientific services
company serving clients across a vast array of technology-related
industries. Through multi-disciplinary expertise in the life,
materials and engineering sciences, EAG helps companies innovate
and improve products, ensure quality and safety, protect
intellectual property and comply with evolving global regulations.
EAG employs 1200+ employees in seven countries, across 20
laboratories serving more than 4,000 clients worldwide.
EAG Laboratories is a trade name of EAG, Inc., majority owned by
Odyssey Investment Partners, LLC, a leading private equity firm
with more than $3.5 billion in
capital under management. Odyssey makes majority, control
investments primarily in established middle-market industrial
manufacturing and business services companies in a variety of
industries. Further information regarding Odyssey Investment
Partners can be found at www.odysseyinvestment.com.
For additional information, visit www.eag.com.
®™Trademark of The Dow Chemical Company ("Dow") or affiliated
companies.
Plextein™ is a trademark of The Dow Chemical Company ("Dow") or
affiliated companies.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/eag-laboratories-licensing-dow-agrosciences-plextein-technology-to-quantitate-allergens-300470049.html
SOURCE Dow AgroSciences